Angelo Kaplan, M.D., Consultant
Dr. Kaplan received his M.D. from the American University of the Caribbean School of Medicine in St. Maarten, with an emphasis on Anatomical and Clinical Pathology. He received clinical training from UCLA and Keck School of Medicine faculty at Kern Medical Center and the VA Greater Los Angeles Healthcare System. Dr. Kaplan’s experience in oncology research began as an undergraduate biology student in Dr. James Allison’s Cancer Research Laboratory at UC Berkeley in 2001. In 2005, he joined Chiron as a Research Specialist in the Experimental Pathology Laboratory within Oncology Drug Development. At Chiron (subsequently Novartis), Dr. Kaplan supported pharmacology, target identification, and toxicology studies with high-throughput histopathology and molecular pathology analysis, including hybridoma screening by IHC, biomarker development and validation, and TMA construction. Dr. Kaplan has extensive experience performing specialized tissue-based assays. He is an author on publications in journals such as Neoplasia and Journal of Anatomy.
With over ten years of research experience in both academia and industry, Dr. Kaplan is excited to be working with Ensigna Biosystems to provide quality molecular pathology and histology support to a wide variety of research clients.
Claude Schaem, M.D., Consultant
Dr. Schaem is a board-certified anatomical pathologist. She completed her Medicine studies as well as Surgical and Anatomic Pathology Specialty Practice in Rouen and Paris, France. She relocated to California in 1995 and completed a two-year residency in surgical pathology at Kaiser Permanente, San Francisco. She then undertook a one-year fellowship in hematopathology in San Francisco, followed by one year of research in surgical pathology at Stanford University. Dr. Schaem has worked as a consultant in private practice and in several biotech companies including Genentech and Novartis from 2000 to 2014.
Francisco Uzal, D.V.M., M.Sc., Ph.D., DAVCP, Consultant
Dr. Francisco Uzal is a highly experienced research and diagnostic pathologist and a Diplomat of American College of Veterinary Pathologist. He is internationally recognized for his accomplishments and his strong interest in studying pathogenesis of disease. Most of his research has involved studies to elucidate the mechanism of action of clostridial toxins. Dr. Uzal has developed several animal models to study clostridial diseases in human and animals, and has authored more than 180 peer reviewed articles.